Guangzhou JOYO Pharma Co., Ltd

Quick facts

Phase 3 pipeline

• Cross-over to JYP0322 · Diabetes
  JYP0322 is a small molecule that targets the SGLT2 receptor.
• JYP0322 tablets · Diabetes
  JYP0322 tablets are a small molecule drug that targets the SGLT2 receptor.

Phase 2 pipeline

• Intravenous Glucocorticoids · Oncology
  Glucocorticoids exert their effects by binding to the glucocorticoid receptor (GR) in the cytoplasm.
• JYP0015
• JYP0061
• SC1011

Phase 1 pipeline

• DC371739
• DC371739 Tablets
• Singletine · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Guangzhou JOYO Pharma Co., Ltd portfolio CI brief
• Guangzhou JOYO Pharma Co., Ltd pipeline updates RSS